Skip to main content
. 2016 Nov 21;16:231. doi: 10.1186/s12872-016-0416-y

Table 2.

Univariate and multivariate Cox regression analyses in terms of VT/VF recurrence

Univariate analysis Multivariate analysis
Variables Hazard ratio 95% CI p-value Hazard ratio 95% CI p-value
Atrial fibrillation (paroxysmal and persistent) 1.095 0.584 ~ 2.052 0.777
LVEF (%) 0.986 0.970 ~ 1.001 0.074
LVEF ≦ 30% 1.995 1.064 ~ 3.740 0.031
LVEDV (mL) 1.004 1.000 ~ 1.007 0.028
LVEDV > 163.5 mL 2.042 1.170 ~ 3.562 0.012 2.549 1.249 ~ 5.201 0.010
LVESV (mL) 1.004 1.001 ~ 1.008 0.025
Heart failure NYHA functional class ≧ 3 1.293 0.688 ~ 2.430 0.425
QRS width (msec) 1.008 1.000 ~ 1.016 0.059
QRS width > 125 msec 2.067 1.003 ~ 4.260 0.049 2.173 1.030 ~ 4.586 0.042
Ischemic cardiomyopathy 0.998 0.580 ~ 1.717 0.995
Dilated cardiomyopathy 0.851 0.437 ~ 1.655 0.634
Anti-arrhythmic drugs 0.611 0.298 ~ 1.252 0.178
Post VT ablation 0.844 0.272 ~ 2.615 0.768

*Abbreviations: VT ventricular tachycardia, VF ventricular fibrillation, CI confidence interval, LVEF left ventricular ejection fraction, LVEDV left ventricular end diastolic volume, LVESV left ventricular end systolic volume, NYHA New York Heart Association